about
The value of combining blood culture and SeptiFast data for predicting complicated bloodstream infections caused by Gram-positive bacteria or Candida species.Micafungin at physiological serum concentrations shows antifungal activity against Candida albicans and Candida parapsilosis biofilms.Autochthonous Crimean-Congo Hemorrhagic Fever in Spain.Legionella micdadei, a new cause of prosthetic joint infection.Are incidence and epidemiology of anaerobic bacteremia really changing?The search for endocarditis in patients with candidemia: a systematic recommendation for echocardiography? A prospective cohort.Antifungal stewardship in a tertiary-care institution: a bedside intervention.The NOVA score: a proposal to reduce the need for transesophageal echocardiography in patients with enterococcal bacteremia.Infective endocarditis in patients with cancer: a consequence of invasive procedures or a harbinger of neoplasm?: A prospective, multicenter cohort.Is it feasible to diagnose catheter-related candidemia without catheter withdrawal?Is biofilm production a predictor of catheter-related candidemia?Is catheter-related candidemia a polyclonal infection?Catheter-related bloodstream infections caused by Gram-negative bacteria.Campylobacter bacteremia: clinical characteristics, incidence, and outcome over 23 years.Inonotosis in Patient with Hematologic Malignancy.Biofilm production is not associated with poor clinical outcome in 485 patients with Staphylococcus aureus bacteraemia.Activity of maltodextrin and vancomycin against staphylococcus aureus biofilm.Central venous catheter colonization with Staphylococcus aureus is not always an indication for antimicrobial therapyProspective, randomised study of selective versus routine culture of vascular catheter tips: patient outcome, antibiotic use and laboratory workloadInfectious and Non-Infectious Neurologic Complications in Heart Transplant RecipientsRecurrent Escherichia coli Bloodstream Infections356. Bronchoalveolar Lavage Fluid Cytology by GMS Stain for the Diagnosis of Invasive Pulmonary Aspergillosis in Patients With Hematologic Malignancies: Analysis of 67 Episodes1488. Invasive Pulmonary Aspergillosis in Patients with Solid Tumors: Risk Factors and Predictors of Clinical Outcomes[Prognostic factors of mortality during the episode of pneumonia due to Pneumocystis carinii in patients with HIV infection]Bronchoalveolar Lavage Fluid Cytology in Culture-Documented Invasive Pulmonary Aspergillosis in Patients with Hematologic Diseases: Analysis of 67 EpisodesA Case-Control Study of Real-Life Experience with Ceftolozane-Tazobactam in Patients with Hematologic Malignancy and Pseudomonas aeruginosa InfectionSearching for the best agent for antibiotic prophylaxis in patients undergoing transcatheter aortic valve implantationInvasive pulmonary aspergillosis in patients with solid tumours: risk factors and predictors of clinical outcomesA retrospective cohort of invasive fusariosis in the era of antimould prophylaxis
P50
Q30586802-AAD96927-0E01-4582-BA8C-FFCB7DBB9FD5Q34057572-239FF92E-7429-418E-B67A-68925BF8860AQ34558668-1445C85F-0CCD-4C10-A6BD-67DC4470A68BQ35192153-293D89A0-556C-4FF4-B906-89EA2F062FC1Q41199404-C3A44697-A440-46F3-AF61-B2C7D280F263Q41237086-7E3D86BD-69DF-441C-8699-8E8BD0D0BFB8Q41444810-91248ACF-3A08-482D-87B3-ACCF7522AED2Q41670980-15F10201-611C-4D4B-8F03-99DC1557CFE1Q41996071-678BD0AB-D6D3-443C-8002-993BD4CA4EC4Q42214483-B315A50A-6C2C-4031-AB88-62151CA1A724Q42217263-D7EBFE63-DC98-4EBD-A35D-FBCE79BAD23BQ42224230-0B3CF7EC-87C1-4AF0-AB94-7868F940F1C3Q42242117-291494E2-2AA9-4384-9B60-439964AD38EBQ43917016-8BDF3837-222D-4B96-B191-A7F96D7806B0Q49411731-86E2D502-A8FC-43B3-978F-2DF734E5F638Q50125821-EB881EC6-49FD-41E0-B52B-3349E3A39691Q51768367-56116012-26BC-4528-B431-BF348FB799ACQ57568983-74F748BC-9D25-4EFB-A077-5B3DDDA637D5Q57569093-996A9606-368C-4CC1-8C20-62B1F7DD657CQ57569126-342230A0-2F51-42B5-92CA-6CB194466CAFQ57569159-CB101C86-0038-4B1F-845E-B4A7377C3FFFQ59333992-4DBC04F6-FC83-41D6-9C7E-37ED74F174EDQ59334556-9516E0CF-CDC7-42F4-811C-09F18275E06FQ74674794-86350396-EE9C-4C8E-AD0D-3D4CB38EADB0Q90320873-2E7B6829-B83E-46D7-B334-0DD5822F42A9Q90364673-1AABC563-2408-4A07-A674-75D44669EF82Q90380960-7E7FE124-A0DF-49CE-A0B4-A300A383723CQ91536274-C25E3DAE-8933-4731-AEED-E3D26A5E9CC0Q92973303-74EC7C5E-F513-4C3C-A4DD-D6FF554466C5
P50
description
researcher ORCID ID = 0000-0003-1189-1120
@en
wetenschapper
@nl
name
A Fernández-Cruz
@ast
A Fernández-Cruz
@en
A Fernández-Cruz
@nl
type
label
A Fernández-Cruz
@ast
A Fernández-Cruz
@en
A Fernández-Cruz
@nl
prefLabel
A Fernández-Cruz
@ast
A Fernández-Cruz
@en
A Fernández-Cruz
@nl
P31
P496
0000-0003-1189-1120